4535 Wilfrid-Hamel Boulevard
QC G1P 2J7
Canada - Map
DiagnoCure Inc., a life sciences company, develops and commercializes cancer diagnostic tests for the detection and management of cancer. The company primarily focuses on molecular diagnostic tests. It offers PCA3 test for the diagnosis of prostate cancer; and Guanylyl Cyclase C (GCC) marker and Previstage GCC colorectal cancer staging test for use in colorectal cancer management. The company also provides gene expression and copy number variation analysis, mutation detection, SNP genotyping, and platform and laboratory environment services. DiagnoCure Inc. was founded in 1994 and is headquartered in Quebec, Canada.
|Dr. Yves Fradet M.D., F.R.C.S.,
Chief Exec. Officer, Pres, Co-Founder, Chief Medical Officer and Director
|Mr. Frederic Boivin ,
Interim Chief Financial Officer and Sr. Director of Fin. & Admin.
|Mr. Andrew J. Sheldon B.Sc (Hons), BAS,
|Ms. Danielle Allard M.Sc.,
Sr. Director of Corp. Affairs and Corp. Sec.
|Mr. Pierre Lapalme ,
Advisor To The Pres
|Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.|
|Currency in CAD.|